Innoprot is a biotechnology company provider of Cell-Based Assays for drug discovery & development applications. Innoprot offers a wide range of stable cell lines and primary cells fully validated for High- Troughput Screening and High Content Screening. Stable cell lines developed by Innoprot are focused on drug discovery targeting mainly GPCRs, Nuclear hormone receptors, enzymes implicated in neurodegenerative diseases and ion channels.
Innoprot has a proprietary technology for High Content Screening, which allow monitor changes in the concentrations of intracellular cAMP or Calcium by fluorescence imaging.
Innoprot also offers custom assay development and High Content Screening Services, providing solutions to speed up the drug discovery campaigns of the customers.
Company Details
- Employees
- 16
- Founded
- -
- Address
- Edificio 502, Primera Planta, Derio,bizkaia 48160,spain
- Phone
- +34 944005355
- in****@****rot.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- innoprot.com
- Keywords
- Drug Discovery & Development, High Content Screening, Cell based assays, drug screening, Fluorescence Imaging.
- HQ
- Derio, Bizkaia
Innoprot Questions
Innoprot's helpline number is +34 944005355
Innoprot's website is innoprot.com
Innoprot's LinkedIn profile is https://es.linkedin.com/company/innoprot
Innoprot has
16 employees.
View email and phone details for 16
employees at Innoprot.
Innoprot's industry is
Biotechnology Research
Innoprot's top competitors are
Biolan Health,
Abyntek Biopharma | Bioreactivos,
Histocell. Regenerative Medicine,
Oncomatryx Biopharma,
Vivebiotech,
Cancerappy,
Mikrobiomik,
Faes Farma,
Img Pharma Biotech,
Hawk Biosystems.
Innoprot's support email address is innoprot@innoprot.com
Innoprot's categories are Biotechnology Research
Innoprot's founding year is 2007
